A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
01/2000
01/05/2000	CN1047935C Direct compression cholestry ramine tablet and solvent-free coating thereof
01/04/2000	US6011136 Inhibitor of tumor necrosis factor; antiinflammatory agents
01/04/2000	US6011068 Carbocyclic-alkyl secondary amines
01/04/2000	US6011063 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
01/04/2000	US6011059 Acyl guanidine sodium/proton exchange inhibitors and method
01/04/2000	US6011057 Methods for inhibiting uterine fibroid disease
01/04/2000	US6011049 Combinations for diabetes
01/04/2000	US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives
01/04/2000	US6010877 cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor
01/04/2000	CA2194103C Polypeptides useful as calcium channel blockers
01/04/2000	CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides
01/02/2000	CA2269999A1 Novel compound
12/1999
12/30/1999	CA2244211A1 Novel compounds
12/29/1999	WO1999067408A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999	WO1999067407A2 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof
12/29/1999	WO1999067279A1 Compounds of unstable dipeptidyl peptidase iv inhibitors
12/29/1999	WO1999067278A1 Prodrugs of dipeptidyl peptidase iv inhibitors
12/29/1999	WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999	WO1999067262A1 Adenosine derivatives
12/29/1999	WO1999067258A1 Arylsulfonanilide phosphates
12/29/1999	WO1999067230A1 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
12/29/1999	WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/29/1999	WO1999066930A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999	WO1999066929A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999	WO1999066925A1 Protease inhibitors
12/29/1999	WO1999066918A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999	WO1999066914A2 Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-l-carnitine and hypericin
12/29/1999	WO1999051626A3 Template associated npy y2-receptor agonists
12/29/1999	EP0966975A2 Diagnostic agents for pancreatic exocrine function
12/29/1999	EP0966470A1 Dioxino derivatives and their use as therapeutic agents
12/29/1999	EP0966462A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
12/29/1999	EP0966460A1 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
12/29/1999	EP0966455A1 Oxiran carboxylic acids for the treatment of diabetes
12/29/1999	EP0966447A1 Small molecules useful in the treatment of inflammatory disease
12/29/1999	EP0966443A1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
12/29/1999	EP0966295A1 Calcareous material
12/29/1999	EP0938477A4 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
12/29/1999	EP0587711B1 Trace element-rich additive, method for preparing same, preparation in which the additive is included and use thereof
12/29/1999	EP0379483B1 1,2,3,4,10,14b-HEXAHYDRODIBENZO c,f]PYRAZINO- 1,2-a]AZEPINO DERIVATIVES
12/29/1999	CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999	CN1239952A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors
12/29/1999	CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999	CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999	CA2336192A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999	CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999	CA2336135A1 Mumbaistatin, a process for its production and its use as a pharmaceutical
12/29/1999	CA2335992A1 Prodrugs of dipeptidyl peptidase iv inhibitors
12/29/1999	CA2335978A1 Compounds of unstable dipeptidyl peptidase iv inhibitors
12/29/1999	CA2335876A1 Protease inhibitors
12/29/1999	CA2335858A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
12/29/1999	CA2335559A1 Arylsulfonanilide phosphates
12/29/1999	CA2335366A1 Compositions and methods for treating elevated blood cholesterol
12/29/1999	CA2329939A1 Transgenetic non-human animal which comprises an inactive peg3 gene, and the use thereof
12/29/1999	CA2329755A1 Synthetic somatostatin immunogen for growth promotion in farm animals
12/28/1999	US6008248 An isotonic mixtures comprising medium-chain triglycerides, vegetable oils and fish oil for treating inflammatory reaction, or an increased risk of vascular thrombosis, or severe cardiac arrythmia
12/28/1999	US6008242 Administering 1-3,4-trans-2,2-dimethy-3-phenyl-4-(4-(2-(pyrrolidin-1-yl)etho xy)phenyl)-7-methoxychroman
12/28/1999	US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999	US6007810 Chondroitinase compositions
12/28/1999	CA2155169C Process and compositions for activating the differentiation of preadipocyte cells and related therapeutic treatments
12/23/1999	WO1999066075A2 Diagnostic method based on quantification of extramitochondrial dna
12/23/1999	WO1999065942A1 Cyclic somatostatin analogs
12/23/1999	WO1999065941A1 Insulin analogue
12/23/1999	WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999	WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999	WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999	WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999	WO1999065895A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
12/23/1999	WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999	WO1999065877A1 Therapeutic biaryl derivatives
12/23/1999	WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999	WO1999065512A1 Medicinal compositions containing fibroblast growth factor-related peptides
12/23/1999	WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999	WO1999065487A1 Inhibitors of serotonin reuptake
12/23/1999	WO1999065476A2 COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO)
12/23/1999	WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999	DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999	CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999	CA2335322A1 Inhibitors of serotonin reuptake
12/23/1999	CA2335184A1 Cyclic somatostatin analogs
12/23/1999	CA2334859A1 Insulin analogue
12/23/1999	CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	CA2330840A1 Diagnostic method based on quantification of extramitochondrial dna
12/22/1999	EP0965587A1 Tetrahydropyridinyl- and piperidinyl Inhibitors of serotonin reuptake
12/22/1999	EP0965578A1 Novel triglyceride and composition comprising the same
12/22/1999	EP0965339A1 Tabletted preparation
12/22/1999	EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999	EP0964692A1 Use of glp-1 or analogs in treatment of myocardial infarction
12/22/1999	EP0923382A4 Compositions of plant carbohydrates as dietary supplements
12/22/1999	EP0758312B1 Substituted fused and bridged bicyclic compounds as therapeutic agents
12/22/1999	EP0726954B1 Cytokine antagonists
12/22/1999	EP0668785B1 System and method for providing a sterile medical solution containing glucose or and glucose-like compounds
12/22/1999	CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/22/1999	CN1047520C Medicine of lowering blood lipid levels
12/21/1999	US6005117 Imino compounds, process for their preparation and their use as victronectin antagonists
12/21/1999	US6005010 Cardiovascular disorders, antiarrhythmia agents and antiischemic agents
12/21/1999	US6004996 Tetrahydrolipstatin containing compositions
12/21/1999	US6004987 Use of ligands which are specific for RXR receptors
12/21/1999	US6004983 Analgesics; antiinflammatory, antiarthritic and antidiabetic agents
12/21/1999	US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods

1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 1298